Basic Information
AVM Biotechnology is a clinical-stage company developing AVM0703, a proprietary and innovative treatment option for cancer and autoimmune diseases. AVM is passionate about delivering effective, safe, rapid, and accessible drugs.
AVM BIOTECHNOLOGY LLC
Seattle,Washington,United States of America
15~50 people
January 01, 2008
jdalpez@avmbiotech.com